These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19526235)

  • 1. Myocardial perfusion quantitation with PET: time to do our homework.
    Fricke E
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1592-3. PubMed ID: 19526235
    [No Abstract]   [Full Text] [Related]  

  • 2. SPECT Myocardial Perfusion Imaging: Poststress, End Systolic Images and the Ongoing Effort to Improve Diagnostic Accuracy.
    Gewirtz H
    J Nucl Med; 2015 Dec; 56(12):1813-4. PubMed ID: 26315833
    [No Abstract]   [Full Text] [Related]  

  • 3. ⁸²Rb PET/CT: entering a new area of myocardial perfusion imaging?
    Valenta I; Schindler TH
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1231-2. PubMed ID: 22652982
    [No Abstract]   [Full Text] [Related]  

  • 4. SPECT myocardial blood flow quantitation toward clinical use: a comparative study with
    Hsu B; Hu LH; Yang BH; Chen LC; Chen YK; Ting CH; Hung GU; Huang WS; Wu TC
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):117-128. PubMed ID: 27585576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.
    Kazakauskaitė E; Žaliaduonytė-Pekšienė D; Rumbinaitė E; Keršulis J; Kulakienė I; Jurkevičius R
    Medicina (Kaunas); 2018 Jul; 54(3):. PubMed ID: 30344278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of radiolabeled compounds for myocardial perfusion imaging.
    Lin X; Zhang J; Wang X; Tang Z; Zhang X; Lu J
    Curr Pharm Des; 2012; 18(8):1041-57. PubMed ID: 22272824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET should not replace routine SPECT MPS for the assessment of patients with known or suspected CAD.
    Stirrup JE; Underwood SR
    J Nucl Cardiol; 2017 Dec; 24(6):1960-1964. PubMed ID: 28836225
    [No Abstract]   [Full Text] [Related]  

  • 8. Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques?
    Caobelli F; Farina D; Pizzocaro C; Guerra UP
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1970-2. PubMed ID: 22926711
    [No Abstract]   [Full Text] [Related]  

  • 9. PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro.
    Maddahi J; Packard RRS
    J Nucl Cardiol; 2017 Dec; 24(6):1955-1959. PubMed ID: 28397181
    [No Abstract]   [Full Text] [Related]  

  • 10. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Myocardial Blood Flow With Positron Emission Tomography and Single-Photon Emission Computed Tomography for Diagnosis of Cardiac Allograft Vasculopathy.
    Ruddy TD; Wells RG
    Circ Cardiovasc Imaging; 2023 Jun; 16(6):e015593. PubMed ID: 37313747
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial blood flow quantitation with the SPECT technique: Is it ready to be a substitute for PET myocardial blood flow quantitation?
    Fang W; Hsu B
    J Nucl Cardiol; 2022 Dec; 29(6):3152-3154. PubMed ID: 34180028
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and nature of extracardiac findings in PET/CT myocardial perfusion imaging.
    David S; Packard RRS
    J Nucl Cardiol; 2023 Aug; 30(4):1469-1473. PubMed ID: 37012524
    [No Abstract]   [Full Text] [Related]  

  • 14. Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography.
    Cheng K; Tan ST; Wechalekar K; Keramida G; de Silva R
    J Nucl Cardiol; 2024 Mar; 33():101803. PubMed ID: 38219971
    [No Abstract]   [Full Text] [Related]  

  • 15. PET-Based Imaging of Ischemic Heart Disease.
    Chen K; Miller EJ; Sadeghi MM
    PET Clin; 2019 Apr; 14(2):211-221. PubMed ID: 30826019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron-emitting myocardial blood flow tracers and clinical potential.
    Schindler TH
    Prog Cardiovasc Dis; 2015; 57(6):588-606. PubMed ID: 25637500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When should myocardial perfusion imaging be a first-test choice?
    Al Rifai M; Winchester D
    J Nucl Cardiol; 2024 Mar; 33():101824. PubMed ID: 38360263
    [No Abstract]   [Full Text] [Related]  

  • 18. Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification.
    Mannarino T; Assante R; D'Antonio A; Zampella E; Cuocolo A; Acampa W
    Cardiol Clin; 2023 May; 41(2):141-150. PubMed ID: 37003672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Perfusion Imaging: The Gatekeeper and Advisor.
    Zaman MU; Fatima N
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):259-261. PubMed ID: 29615162
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Utility of Enhanced Relative Activity Recovery on Systolic Myocardial Perfusion SPECT: Lessons from PET.
    Kitkungvan D; Vejpongsa P; Korrane KP; Sdringola S; Gould KL
    J Nucl Med; 2015 Dec; 56(12):1882-8. PubMed ID: 26272807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.